medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2020, Number 1

Next >>

Rev Nefrol Dial Traspl 2020; 40 (1)

Kidney health for everyone everywhere – from prevention to detection and equitable access to care

Kam-Tao LP, Garcia-Garcia G, Siu-Fai L, Sharon AL, Wing-Shing FW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K

Language: English
References: 56
Page: 1-13
PDF size: 433.66 Kb.


Text Extraction

INTRODUCTION
Around 850 million people currently are affected by different types of kidney disorders.
Up to one in ten adults worldwide has chronic kidney disease (CKD), which is invariably irreversible and mostly progressive. The global burden of CKD is increasing, and CKD is projected to become the 5th most common cause of years of life lost globally by 2040.(2) If CKD remains uncontrolled and if the affected person survives the ravages of cardiovascular and other complications of the disease, CKD progresses to end-stage renal disease (ESRD), where life cannot be sustained without dialysis therapy or kidney transplantation. Hence, CKD is a major cause of catastrophic health expenditure.


REFERENCES

  1. International Society of Nephrology. United NationsHight Level Meeting on Universal Health Coverage.Moving together to build Kidney Health Worldwide[Internet]. ISN, 2019. Disponible en: https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdf (Consulta: 20/07/2019).

  2. Foreman KJ, Marquez N, Dolgert A, Fukutaki K,Fullman N, McGaughey M, et al. Forecasting lifeexpectancy, years of life lost, and all-cause and causespecificmortality for 250 causes of death: reference andalternative scenarios for 2016-40 for 195 countries andterritories. Lancet. 2018;392(10159):2052-90.

  3. Essue BM, Laba T, Knaul F, Chu A, Van Minh H,Phuong Nguyen TH, et al. Economic burden of chronicill health and injuries for households in low- and middleincomecountries. In: Jamison DT, Gelband H, HortonS, Jha P, Laxminarayan R, Mock CN, et al., eds. Diseasecontrol priorities: improving health and reducing poverty.3rd ed. Washington, DC: World Bank, 2018, p. 121-43.

  4. Luyckx VA, Tuttle KR, Garcia-Garcia G, Gharbi MB,Heerspink HJL, Johnson DW, et al. Reducing majorrisk factors for chronic kidney disease. Kidney Int Suppl.2017;7(2):71-87.

  5. Luyckx VA, Tonelli M, Stanifer JW. The global burdenof kidney disease and the sustainable developmentgoals. Bull World Health Organ. 2018; 96(6):414-22D.

  6. Tonelli M, Muntner P, Lloyd A, Manns BJ, KlarenbachS, Pannu N, et al. Risk of coronary events in peoplewith chronic kidney disease compared with thosewith diabetes: a population-level cohort study. Lancet.2012;380(9844): 807-14.

  7. Kalantar-Zadeh K, Fouque D. Nutritionalmanagement of chronic kidney disease. N Engl J Med.2017;377(18):1765-76.

  8. United Nations General Assembly. Political declarationof the third high-level meeting of the General Assemblyon the prevention and control of non-communicablediseases [Internet]. Oct. 2018. Dsiponible en: https://www.un.org/ga/search/view_doc.asp?symbol=A/73/L.2&Lang=E (Consulta: 20/07/2019).

  9. López AD, Williams TN, Levin A, Tonelli M, SinghJA, Burney PG, et al. Remembering the forgottennon-communicable diseases. BMC Med. 2014;12:200.

  10. Estados Unidos. Centers for Disease Control andPrevention. Picture of America [Internet]. WashingtonDC: CDC, 2019. Disponible en: https://www.cdc.gov/pictureofamerica/index.html (Consulta: 20/07/2019).

  11. Levey AS, Schoolwerth AC, Burrows NR, Williams DE,Stith KR, McClellan W. Comprehensive public healthstrategies for preventing the development, progression,and complications of CKD: report of an expert panelconvened by the Centers for Disease Control andPrevention. Am J Kidney Dis. 2009;53(3):522-35.

  12. Saran R, Robinson B, Abbott KC, Agodoa LYC,Bragg-Gresham J, Balkrishnan R, et al. US Renal DataSystem 2018 Annual Data Report: Epidemiology ofKidney Disease in the United States. Am J Kidney Dis.2019;73(3S1):A7-A8.

  13. Kovesdy CP, Furth SL, Zoccali C; World KidneyDay Steering Committee. Obesity and kidney disease:hidden consequences of the epidemic. J Ren Nutr.2017;27(2):75-7.

  14. Tantisattamo E, Dafoe DC, Reddy UG, Ichii H, RheeCM, Streja E, et al. Current management of acquiredsolitary kidney. Kidney Int Rep. 2019;4(9):1205-18.

  15. Webster AC, Nagler EV, Morton RL, Masson P. Chronickidney disease. Lancet. 2017;389(10075):1238-52.

  16. Koppe L, Fouque D. The role for protein restrictionin addition to renin-angiotensin-aldosterone systeminhibitors in the management of CKD. Am J KidneyDis. 2019;73(2):248-57.

  17. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKItruly lead to CKD? J Am Soc Nephrol. 2012; 23(6):979-84.

  18. 18) Torres VE, Chapman AB, Devuyst O, GansevoortRT, Grantham JJ, Higashihara E, et al. Tolvaptan inpatients with autosomal dominant polycystic kidneydisease. N Engl J Med. 2012;367(25):2407-18.

  19. Verhave JC, Troyanov S, Mongeau F, Fradette L,Bouchard J, Awadalla P, et al. Prevalence, awareness,and management of CKD and cardiovascular riskfactors in publicly funded health care. Clin J Am SocNephrol. 2014;9(4):713-9.

  20. Chow KM, Szeto CC, Kwan B, Leung CB, Li PK.Public lacks knowledge on chronic kidney disease:telephone survey. Hong Kong Med J. 2014;20(2):139-44.

  21. Ene-Iordache B, Perico N, Bikbov B, Carminati S,Remuzzi A, Perna A, et al. Chronic kidney diseaseand cardiovascular risk in six regions of the world(ISN-KDDC): a cross-sectional study. Lancet GlobHealth. 2016;4(5):e307-19.

  22. Li PK, Weening JJ, Dirks J, Lui SL, Szeto CC, TangS, et al. A report with consensus statements of theInternational Society of Nephrology 2004 ConsensusWorkshop on Prevention of Progression of RenalDisease, Hong Kong, June 29, 2004. Kidney Int Suppl.2005;(94):S2-7.

  23. Vassalotti JA, Stevens LA, Levey AS. Testing forchronic kidney disease: a position statement fromthe National Kidney Foundation. Am J Kidney Dis.2007;50(2):169-80.

  24. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ,Eckardt KU, et al. Chronic kidney disease as a globalpublic health problem: approaches and initiatives - aposition statement from Kidney Disease ImprovingGlobal Outcomes. Kidney Int. 2007;72(3):247-59.

  25. Crowe E, Halpin D, Stevens P; Guideline DevelopmentGroup. Early identification and management of chronickidney disease: summary of NICE guidance. BMJ.2008;337:a1530.

  26. Li PK, Chow KM, Matsuo S, Yang CW, Jha V, BeckerG, et al. Asian chronic kidney disease best practicerecommendations: positional statements for earlydetection of chronic kidney disease from Asian Forumfor Chronic Kidney Disease Initiatives (AFCKDI).Nephrology (Carlton). 2011;16(7):633-41.

  27. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonaldR, Rossini D, et al. Screening for, monitoring, andtreatment of chronic kidney disease stages 1 to 3: asystematic review for the U.S. Preventive Services TaskForce and for an American College of Physicians ClinicalPractice Guideline. Ann Intern Med. 2012;156(8):570-81.

  28. Li PK, Ng JK, Cheng YL, Kwan TH, Leung CB, LauMF, et al. Relatives in silent kidney disease screening(RISKS) study: A Chinese cohort study. Nephrology(Carlton). 2017;22(Suppl. 4):35-42.

  29. Samal L, Linder JA. The primary care perspective onroutine urine dipstick screening to identify patients withalbuminuria. Clin J Am Soc Nephrol. 2013;8(1):131-5.

  30. George C, Mogueo A, Okpechi I, Echouffo-TcheuguiJB, Kengne AP. Chronic kidney disease in low-incometo middle-income countries: the case for increasedscreening. BMJ Glob Health. 2017;2(2):e000256.

  31. Gonzalez-Quiroz M, Nitsch D, Hamilton S,O’Callaghan Gordo C, Saran R, Glaser J, et al. Rationaleand population-based prospective cohort protocol forthe disadvantaged populations at risk of decline ineGFR (CO-DEGREE). BMJ Open. 2019;9(9):e031169.

  32. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL,Powe NR. Screening for proteinuria in US adults: a costeffectivenessanalysis. JAMA. 2003;290(23):3101-14.

  33. Go DS, Kim SH, Park J, Ryu DR, Lee HJ, Jo MW.Cost-utility analysis of the National Health ScreeningProgram for chronic kidney disease in Korea. Nephrology(Carlton). 2019;24(1):56-64.

  34. Komenda P, Ferguson TW, Macdonald K, RigattoC, Koolage C, Sood MM, et al. Cost-effectiveness ofprimary screening for CKD: a systematic review. Am JKidney Dis. 2014;63(5):789-97.

  35. 35) Hwang SJ, Tsai JC, Chen HC. Epidemiology, impactand preventive care of chronic kidney disease in Taiwan.Nephrology (Carlton). 2010;15(Suppl. 2):3-9.

  36. Almaguer M, Herrera R, Alfonso J, Magrans C,Mañalich R, Martínez A. Primary health care strategiesfor the prevention of end-stage renal disease in Cuba.Kidney Int. 2005;68( 97):S4-10.

  37. Alamaguer-López M, Herrera-Valdez R, Díaz J,Rodríguez O. Integration of chronic kidney diseaseprevention into noncommunicable disease programsin Cuba. En: G. Garcia-Garcia, LY Agodoa, KCNorris (eds.). Chronic kidney disease in disadvantagedpopulation. London: Elsevier, 2017, pp. 357-65.

  38. Estados Unidos. Department of Health and HumanServices. Advancing american kidney health [Internet].Disponible en: https://aspe.hhs.gov/system/files/pdf/262046/AdvancingAmericanKidneyHealth.pdf(Consulta: 20/07/2019).

  39. Estados Unidos. Department of Health and HumanServices, Office of the Assistant Secretary for Planningand Evaluation. The Special Diabetes Program forIndians. Estimates of Medicare savings [Internet]. ASPEIssue Brief, may 10 2019. Disponible en: https://aspe.hhs.gov/system/files/pdf/261741/SDPI_Paper_Final.pdf (Consulta: 26/09/2019).

  40. Bello AK, Nwankwo E, El Nahas AM. Prevention ofchronic kidney disease: a global challenge. Kidney IntSuppl. 2005;(98):S11-7.

  41. James MT, Hemmelgarn BR, Tonelli M. Earlyrecognition and prevention of chronic kidney disease.Lancet. 2010; 375(9722):1296-309.

  42. Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G,Hernández-Anaya M, et al. Improving care of patientswith diabetes and CKD: a pilot study for a clusterrandomizedtrial. Am J Kidney Dis. 2008;51(5):777-88.

  43. Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G,et al. Renal function preservation in type 2 diabetesmellitus patients with early nephropathy: a comparativeprospective cohort study between primary healthcare doctors and a nephrologist. Am J Kidney Dis.2006;47(1):78-87.

  44. Cueto-Manzano AM, Martínez-Ramírez HR, Cortes-Sanabria L, Rojas-Campos E. CKD screening andprevention strategies in disadvantaged populations. Therole of primary health care professionals. En: G. Garcia-Garcia, LY Agodoa, KC Norris (eds.). Chronic kidneydisease in disadvantaged population. London: Elsevier,2017, pp. 329-35.

  45. Tapia-Conyer R, Gallardo-Rincon H, Betancourt-Cravioto M. Chronic kidney disease in disadvantagedpopulations: Online educational programs for NCDprevention and treatment. En: G. Garcia-Garcia, LYAgodoa, KC Norris (eds.). Chronic kidney disease indisadvantaged population. London: Elsevier, 2017, pp.337-45.

  46. Bello AK, Levin A, Manns BJ, Feehally J, DruekeT, Faruque L, et al. Kidney Health for Life Initiative.Effective CKD care in european countries: challengesand opportunities for health policy. Am J Kidney Dis.2015;65(1):15-25.

  47. Sharif MU, Elsayed M E, Stack AG. The globalnephrology workforce: emerging threats and potentialsolutions. Clin Kidney J. 2016;9(1):11-22.Recibido en su forma original: 8 de noviembre de 2019Aceptación final: 15 de noviembre de 2019Dr. Philip Kam-Tao LiDepartment of Medicine and Therapeutics, Carol & Richard Yu PD Research Centre,Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, Chinae-mail: philipli@cuhk.edu.hk

  48. Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC.Shortage of healthcare workers in sub-Saharan Africa: anephrological perspective. Clin Nephrol. 2010;74(Suppl1):S129-33.

  49. Cusumano AM, Rosa-Diez GJ, González-Bedat MC.Latin American Dialysis and Transplant Registry:Experience and contributions to end-stage renal diseaseepidemiology. World J Nephrol. 2016;5(5):389-97.

  50. Feehally J, Brusselmans A, Finkelstein FO, Harden P,Harris D, Manuzi G, et al. Improving global health:measuring the success of capacity building outreachprograms: a view from the International Society ofNephrology. Kidney Int Suppl. 2016; 6(2): 42-51.

  51. Harris DC, Dupuis S, Couser WG, Feehally J. Trainingnephrologists from developing countries: does it have apositive impact? Kidney Int Suppl. 2012;2(3):275-8.

  52. Morbidity and mortality of renal dialysis: anNIH consensus conference statement. ConsensusDevelopment Conference Panel. Ann Intern Med.1994;121(1): 62-70.

  53. García-García G, Martínez-Castellanos Y, Renoirte-Lopez K, Barajas-Murguia A, de la Torre-Campos L,Becerra-Muñóz LE, et al. Multidisciplinary care forpoor patients with chronic kidney disease in Mexico.Kidney Int Suppl. 2013;3(2):178-83.

  54. Stanifer JW, Von Isenburg M, Chertow GM, Anand S.Chronic kidney disease care models in low- and middleincomecountries: a systematic review. BMJ Glob Health.2018;3(2):e000728.

  55. Narva AS, Norton JM, Boulware LE. Educatingpatients about CKD: the path to self-managementand patient-centered care. Clin J Am Soc Nephrol.2016;11(4):694-703.

  56. Schatell D. Web-based kidney education: supportingpatient self-management. Semin Dial. 2013;26(2):154-8.




2020     |     www.medigraphic.com